US2014187613A1PendingUtilityA1
METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs
Est. expiryAug 7, 2023(expired)· nominal 20-yr term from priority
C07H 21/02C12N 2330/51C12N 15/113C12N 15/111C12N 2310/141C12N 2310/14C12N 2310/531C12N 2310/111C12N 2330/30A61P 7/00C12N 2310/53A61P 35/02
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to microRNAs, methods of producing microRNAs and methods for using microRNAs.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A precursor microRNA molecule, comprising:
an isolated nucleic acid comprising: a stem-loop structure, wherein a microRNA sequence is incorporated into a stem of the stem-loop structure, and a microRNA flanking sequence flanking at least one end of the stem-loop structure.
2 . The precursor microRNA molecule of claim 1 , wherein the microRNA flanking sequence is between 40 and 2,000 nucleotides in length.
3 . The precursor microRNA molecule of claim 1 , wherein the microRNA sequence and the microRNA flanking sequence are derived from the same microRNA gene.
4 - 5 . (canceled)
6 . The precursor microRNA molecule of claim 1 , wherein the precursor microRNA molecule includes at least two stem-loop structures.
7 . The precursor microRNA molecule of claim 1 , wherein the microRNA flanking sequence is between 40 and 4,000 nucleotides in length.
8 - 9 . (canceled)
10 . The precursor microRNA molecule of claim 1 , wherein the precursor microRNA molecule has microRNA flanking sequences flanking each end of the stem-loop structure.
11 - 13 . (canceled)
14 . A method of altering the productive utilization of a target mRNA, comprising:
contacting a cell with a vector capable of expressing a precursor microRNA of claim 1 wherein the precursor microRNA includes a microRNA sequence capable of altering the productive utilization of the target mRNA.
15 . The method of claim 14 , wherein the precursor microRNA is specific for a cancer-associated RNA.
16 . The method of claim 14 , wherein the precursor microRNA is specific for a viral RNA.
17 . The method of claim 14 , wherein the method is performed in vivo.
18 - 22 . (canceled)
23 . A vector for producing a precursor microRNA wherein the vector includes a sequence encoding a precursor microRNA, including a microRNA sequence and a microRNA flanking sequence, and at least one promoter element.
24 . The vector of claim 23 , wherein the vector is a viral vector.
25 . The vector of claim 24 , wherein the viral vector is a retroviral vector.
26 . The vector of claim 23 , wherein the at least one of the promoter is an inducible promoter.
27 - 29 . (canceled)
30 . A host cell transfected with the vector of claim 23 .
31 - 32 . (canceled)
33 . A method for modulating hematopoiesis, comprising:
contacting a hematopoietic cell with a vector capable of expressing a precursor microRNA of claim 1 wherein the precursor microRNA includes a microRNA sequence capable of altering accumulation of a protein involved in hematopoiesis.
34 . A method of making the vector of claim 23 , the method comprising providing a vector comprising a microRNA flanking sequence and at least one promoter element, inserting a sequence encoding a stem-loop structure into the vector in the context of the microRNA flanking sequence, wherein a microRNA sequence is incorporated into a stem of the stem-loop structure.
35 . The method of claim 34 , wherein the vector comprises two microRNA flanking sequences, and wherein the sequence encoding a stem-loop structure is flanked by the two microRNA flanking sequences.Join the waitlist — get patent alerts
Track US2014187613A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.